InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...Senesco Technologies Enters Into Agreements For Additional $700,000 In Financing
... as well as other factors expressed from time to time in the Company's periodic filings with the SEC. As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...Zimmer Launches New Medical Education and BioSkills Training Program
... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...Senesco Technologies Enters Into Agreement For Up To $1.0 Million In Financing
... as well as other factors expressed from time to time in the Company's periodic filings with the SEC. As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...ArborGen and Senesco Announce Wood Quality Results
... AMEX, as well as other factors expressed from time to time in Senesco's periodic filings with the Securities and Exchange Commission (the " SEC" ). As a result, this press release should be read in conjunction with Senesco's periodic filings with the SEC. The forward-looking statements contained herein are ...Poniard Pharmaceuticals Files Shelf Registration
... is intended to provide the Company with flexibility to facilitate the periodic sale of its securities, subject to market conditions and the Company's ... and the risks and uncertainties described in the Company's current and periodic reports filed with the Securities and Exchange Commission (SEC), including ...Senesco Technologies Reports Third Quarter Fiscal 2009 Financial Results
... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...United Therapeutics Reports First Quarter 2009 Financial Results
... subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could ... statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, ...InterMune Reports First Quarter 2009 Financial Results and Business Highlights
... Form 10-K filed with the SEC on March 16, 2009 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...Palatin Technologies' Listing Compliance Plan Accepted by NYSE Alternext US
... on the Exchange during the plan period through June 23, 2010, subject to periodic review by the Exchange to determine if Palatin is making progress ... its intellectual property, and other factors discussed in the Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not ...InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...InterMune Announces Issuance of U.S. Patent for ITMN-191
... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the " SEC" ). As a ... this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC. Completion of the offering is subject to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...Palatin Technologies Receives Notification Letter from NYSE Alternext US
... its listing during the plan period through July 23, 2010, subject to periodic review by the Exchange to determine if it is making progress consistent ... its intellectual property, and other factors discussed in the Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not ...Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths
... that the surface plasmon resonances of metal nanoparticles in a periodic array can have considerably narrower spectral widths than those of ... Further, as the optical fields are significantly more intense in a periodic array, the method could improve the sensitivity of detecting molecules at ...InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...United Therapeutics Reports Third Quarter 2008 Financial Results
... subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could ... statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, ...InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) risks related to ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...Watson Pharmaceuticals Reports Second Quarter 2008 Results
... mix between the Company's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net ... products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but ...InterMune Reports Second Quarter 2008 Financial Results and Business Highlights
... Form 10-K filed with the SEC on March 14, 2008 (the "Form 10-K") and other periodic reports filed with the SEC, including the following: (i) the fact that ... other factors discussed in detail in the Form 10-K and InterMune's other periodic reports filed with the SEC, all of which are available via InterMune's web ...United Therapeutics Reports Second Quarter 2008 Financial Results
... subject to certain risks and uncertainties, such as those described in our periodic reports filed with the Securities and Exchange Commission, that could ... statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, ...Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
... mix between the Company's Brand, Generic and Distribution business units; periodic dependence on a small number of products for a material source of net ... products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but ...Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
... as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are ...Zimmer Holdings Announces Support for Elimination of Super-Majority Voting Requirements
... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...Zimmer Announces Settlement of Federal Investigation
... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
... a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We ... information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue ...